Aurobindo Pharma Limited has informed the National Stock Exchange of India Limited (NSE) and BSE Limited about its officials' scheduled participation in an investor/analyst meeting.
The nature of the event is a scheduled investor relations activity. Officials of the company will be participating in the Goldman Sachs Asia Leaders Conference Hong Kong 2026. The meeting is scheduled to take place on September 1-2, 2026. The timing for the interactions is from 09:00 AM to 05:00 PM Hong Kong Time (HKT).
The type of meetings will include both one-on-one and group meetings. The location of the conference is Hong Kong.
The company has stated that the schedule is subject to change, and any change may occur due to exigencies on the part of either the Investor or the Company.
A critical disclosure is that no unpublished price sensitive information (UPSI) is intended to be discussed during these interactions.
The letter was signed by B. Adi Reddy, Company Secretary, on August 25, 2026.